Abstract | BACKGROUND: OBJECTIVES: To compare the efficacy, recurrence rate, cosmetic outcomes and safety between Er:YAG AFL-assisted MAL- PDT (Er:YAG AFL- PDT) and standard MAL- PDT. METHODS: Twenty-one patients with a total of 58 BD lesions randomly received either one session of Er:YAG AFL- PDT or two sessions of MAL- PDT in two symmetrical areas. Er:YAG AFL therapy was performed with 550-600 μm ablation depth, level 1 coagulation, 22% treatment density and a single pulse. MAL cream was then applied under occlusion for 3 h and illuminated with a red light-emitting diode lamp at 37 J cm(-2) . A second session of MAL- PDT was administered 7 days later. Overall response rate, recurrence rate, cosmetic outcomes and safety were assessed at 1 week, 3 and 12 months after treatment. RESULTS: After 3 months, Er:YAG AFL- PDT was significantly more effective (93.8%) than MAL- PDT (73.1%; P = 0.031), and the recurrence rate was significantly lower for Er:YAG AFL- PDT (6.7%) than MAL- PDT (31.6%) at 12 months (P = 0.022). No significant difference was found between Er:YAG AFL- PDT and MAL- PDT in terms of cosmetic outcomes or safety. CONCLUSIONS: Er:YAG AFL- PDT showed significantly higher efficacy and lower recurrence rate than did standard MAL- PDT for treating lower extremity BD in an Asian population.
|
Authors | D Y Ko, K H Kim, K H Song |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 170
Issue 1
Pg. 165-72
(Jan 2014)
ISSN: 1365-2133 [Electronic] England |
PMID | 24102369
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 British Association of Dermatologists. |
Chemical References |
- Photosensitizing Agents
- methyl 5-aminolevulinate
- Aminolevulinic Acid
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Aminolevulinic Acid
(analogs & derivatives, therapeutic use)
- Asian People
- Bowen's Disease
(ethnology, therapy)
- Female
- Follow-Up Studies
- Humans
- Laser Therapy
(methods)
- Lasers, Solid-State
(therapeutic use)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(ethnology, etiology)
- Photochemotherapy
(adverse effects, methods)
- Photosensitizing Agents
(therapeutic use)
- Prospective Studies
- Skin Neoplasms
(therapy)
- Treatment Outcome
|